N. Lebou6ier et al. / Tetrahedron Letters 43 (2002) 2827–2830
Ph
2829
Ph
H
OH
H
OH
Si
N
N
b
a
1a,b
F3C
F3C
63%
90%
4a (R,R) : 4b (R,S)
70 : 30f,g
5a : 5b
54 : 46f
73%
c
66%
d
Ph
Ph
H
N
OH
NH2
H
OH
N
CO2H
e
COPh
F3C
CO2Et
F3C
6a (R,R) (92%<de)f
90%h
F3C
(R)-(+)-3-amino-4,4,4-
trifluorobutanoic acid 8
7a (R,R) :7b (R,S)
84 : 16f,g
Scheme 3. Reactions of 1a,b with various silylated nucleophiles. (a) AllylTMS, CH2Cl2, BF3·OEt2. (b) Bis-trimethylsilyl-acetylene,
CH2Cl2, BF3·OEt2, reflux 4 days. (c) H2CꢀC(OTMS)Ph, CH2Cl2, BF3·OEt2. (d) H2CꢀC(OTMS)OEt, CH3CH2CN, BF3·OEt2, 1 h
30 min reflux. (e) Pb(OAc)4, CH2Cl2:MeOH (2:1) then HCl conc., reflux, 4 h, H+ resin. (f) Determined by 19F NMR integration
of the CF3 signals of each diastereomer in the crude mixture. (g) A pure fraction of both isomers was obtained after silica gel
chromatography separation. (h) Overall yield from a pure sample of 7a.
T. Org. Lett. 2000, 2, 1577–1579; (f) Blond, G.; Billard,
T.; Langlois, B. R. J. Org. Chem. 2001, 66, 4826–4830;
(g) Billard, T.; Langlois, B. R. J. Org. Chem. 2002, 67,
997–1000. For related reactions, see: (h) Crousse, B.;
Narizuka, S.; Bonnet-Delpon, D.; Be´gue´, J.-P. Synlett
2001, 679–681; (i) Crousse, B.; Be´gue´, J.-P.; Bonnet-Del-
pon, D. J. Org. Chem. 2000, 5009–5013; (j) Abouabdel-
lah, A.; Be´gue´, J.-P.; Bonnet-Delpon, D.; Nga, T. T. T. J.
Org. Chem. 1997, 62, 8826–8833; (k) Gong, Y.; Kato, K.;
Kimoto, H. Synlett 2000, 1058–1060.
References
1. Biomedical Frontiers of Fluorine Chemistry; Ojima, I.;
McCarthy, J. R.; Welch, J. T., Eds.; American Chemical
Society: Washington, DC, 1996.
2. (a) Enantiocontrolled Synthesis of Fluoro-organic Com-
pounds; Soloshonok, V. A., Ed.; Wiley: Chichester, 1999;
(b) Asymmetric Fluoroorganic Chemistry: Synthesis,
Applications, and Future Directions; Ramachandran, P.
V., Ed.; American Chemical Society: Washington, DC,
1999.
3. (a) Pirkle, W. H.; Hauske, J. R. J. Org. Chem. 1977, 42,
2436–2439; (b) Wang, Y.; Mosher, H. S. Tetrahedron
Lett. 1991, 32, 987–990; (c) Abe, H.; Amii, H.; Uneyama,
K. Org. Lett. 2001, 3, 313–315; (d) Sakai, T.; Yan, F.;
Kashino, S.; Uneyama, K. Tetrahedron 1996, 52, 233–
244; (e) Enders, D.; Funabiki, K. Org. Lett. 2001, 3,
1575–1577; (f) Soloshonok, V. A.; Avilov, D. V.; Kukhar,
V. P.; Van Meervelt, L.; Mischenko, N. Tetrahedron Lett.
1997, 38, 4671–4674; (g) For a review on [1.3]-proton
shift, see: Soloshonok, V. A. in Ref. 2b, p. 74; (h) For a
review on the use of the sulfinyl chiral auxiliary, see:
Bravo, P.; Zanda, M. in Ref. 2a, p. 107. Bravo, P.;
Bruche, L.; Crucianelli, M.; Zanda, M. in Ref. 2b, p. 98.
4. (a) Prakash, G. K. S.; Mandal, M.; Olah, G. A. Org.
Lett. 2001, 3, 2847–2850; (b) Prakash, G. K. S.; Mandal,
M.; Olah, G. A. Angew. Chem., Int. Ed. Engl. 2001, 40,
589–590.
5. (a) Higashiyama, K.; Ishii, A.; Mikami, K. Synlett 1997,
1381–1382; (b) Higashiyama, K.; Ishii, A.; Miyamoto, F.;
Mikami, K. Tetrahedron Lett. 1998, 39, 1199–1202; (c)
Higashiyama, K.; Ishii, A.; Miyamoto, F.; Mikami, K.
Chem. Lett. 1998, 119–120.
6. (a) Fuchigami, T.; Ichikawa, S.; Konno, A. Chem. Lett.
1989, 1987–1989; (b) Fuchigami, T.; Nakagawa, Y.; Non-
aka, T. J. Org. Chem. 1987, 52, 5489–5491; (c)
Fuchigami, T.; Ichikawa, S. J. Org. Chem. 1994, 59,
607–615; (d) Xu, Y.; Dolbier, W. R. J. Org. Chem. 2000,
65, 2134–2137; (e) Takaya, J.; Kagoshima, H.; Akiyama,
7. (a) Inaba, T.; Kozono, I.; Fujita, M.; Ogura, K. Bull.
Chem. Soc. Jpn. 1992, 65, 2359–2365; (b) Chakraborty, T.
K.; Reddy, G. V.; Hussain, K. A. Tetrahedron Lett. 1991,
32, 7597–7600; (c) Chakraborty, T. K.; Hussain, K. A.;
Reddy, G. V. Tetrahedron 1995, 51, 9179–9190; (d) Dave,
R. H.; Hosangadi, B. D. Tetrahedron 1999, 55, 11295–
11308.
8. Fluorine-containing Amino Acids, Synthesis and Proper-
ties; Kukhar’, V. P.; Soloshonok, V A., Eds.; Wiley:
Chichester, 1995.
9. Data for 2a. Colorless liquid; [h]2D0 +203 (c 0.76, CHCl3);
3
1H NMR l 2.06 (s, 1H), 2.87 (d, JHH=13.4, 1H), 3.65
(dd, 2JHH=10.7, 3JHH=9.5, 1H), 3.82 (dd, 2JHH=10.7,
3JHH=3.8, 1H), 3.90 (dq, 3JHH=13.4, 3JHF=6.7, 1H),
3
3
4.13 (dd, JHH=9.5, JHH=3.8, 1H), 7.18–7.41 (5H); 19F
NMR l −74.2 (d, 3JHF=6.7); 13C NMR l 50.9 (q,
2JCF=34.5), 62.5, 66.9, 113.4, 121.6 (q, 1JCF=281.3),
126.8 (2C), 127.5 (2C), 129.2, 136.3; IR (neat) 3338, 3020,
2934, 1216, 1150; MS m/z 245 (M+1, 49), 227 (5), 218
(65), 213 (100). Anal. calcd for C11H11N2OF3: C, 54.10;
H, 4.54; N, 11.47. Found: C, 54.23; H, 4.52; N, 11.13%.
10. Enantiopure (R)-(+)-3,3,3-trifluoroalanine: (a) Arnone,
A.; Bravo, P.; Capelli, S.; Fronza, G.; Meille, S. V.;
Zanda, M.; Caviccho, G.; Crucianelli, M. J. Org. Chem.
1996, 61, 3375–3387. Corrigenda: J. Org. Chem. 1996, 61,
9635. Enantioenriched 3,3,3-trifluoroalanine: (b) Sakai,
T.; Yani, F.; Uneyama, K. Synlett 1995, 753–754; (c)
Sakai, T.; Yani, F.; Kashino, S.; Uneyama, K. Tetra-
hedron 1996, 52, 233–244; (d) Crucianelli, M.; Battista,